Organ Engineering-How Biofabrication is paving the way for Tissue Products - #BosTechWeek

Tuesday, May 26

11:00am

ETET

Hosted by

^◡^

❛o❛

Organ Engineering-How Biofabrication is paving the way for Tissue Products - #BosTechWeek From lab-grown tissue models used in drug discovery and disease research to the development of implantable tissue therapeutics, biofabrication is bridging a critical gap between experimentation and clinical application. The conversation will highlight how engineered tissues can better replicate human physiology, improve predictive testing, and open new pathways for regenerative medicine. Bringing together perspectives from science, engineering, and entrepreneurship, this event will provide a high-level look at where the field stands today and where it’s headed next. Join us for a fireside chat featuring Christopher S. Chen, a leading scientists in tissue engineering, mechanobiology, and tissue therapuetics. Dr. Chen is the William Fairfield Warren Distinguished Professor of Biomedical Engineering at Boston University, Founding Director of the Biological Design Center, and a Core Faculty member at the Wyss Institute for Biologically Inspired Engineering. His work has helped shape the modern field of engineered tissues and microphysiological systems, advancing how researchers model human biology and develop regenerative therapies. Beyond academia, Dr. Chen has co-founded biotechnology companies translating tissue engineering into real-world therapeutics, including Satellite Bio, a company developing implantable tissue therapeutics for organ failure. He is also part of a recently awarded ARPA-H PRINT program initiative focused on engineering transplant-ready liver grafts and advancing the future of biofabricated organs. The conversation will be hosted by Ricky Solorzano, Founder and CEO of Linton Lifesciences, a Boston-based biofabrication company developing engineered vascular systems, tissue models, and regenerative medicine technologies. Ricky is a biofabrication entrepreneur and former co-founder of Allevi, acquired by 3D Systems, with a focus on translating bioprinting and tissue engineering technologies from the laboratory into scalable platforms. Together, the discussion will explore how biofabrication is bridging the gap between tissue models, implants, and regenerative therapeutics, the technologies enabling the next generation of organ engineering. Attendees will gain insight into the technologies driving progress, the challenges of scaling and translation, and the broader impact of biofabrication on the future of healthcare. This event is part of #BosTechWeek, a week of events hosted by VCs and startups to bring together the tech ecosystem. Learn more at www.tech-week.com

Guest List

53 on the list · 2 Interested

View all

•‿•

ツ

❛o❛